share_log

藥明巨諾-B:董事名單與其角色和職能

JW THERAP-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

HKEX ·  Aug 28, 2024 07:52

Summary by Moomoo AI

藥明巨諾-B(開曼)有限公司於2024年8月28日公布了其董事會成員名單及其在各董事會委員會中的角色和職能。董事會包括執行董事劉敏先生,非執行董事李怡平醫生(主席)、高星女士、Sungwon Song博士和劉誠博士,以及獨立非執行董事何建昌先生、Debra Yu醫生和陳炳鈞先生。公司設有四個董事會委員會,包括審核委員會、薪酬委員會、提名委員會和業務發展及策略委員會。何建昌先生和Debra Yu醫生分別擔任數個委員會的主席,而其他董事成員則擔任委員會成員。
藥明巨諾-B(開曼)有限公司於2024年8月28日公布了其董事會成員名單及其在各董事會委員會中的角色和職能。董事會包括執行董事劉敏先生,非執行董事李怡平醫生(主席)、高星女士、Sungwon Song博士和劉誠博士,以及獨立非執行董事何建昌先生、Debra Yu醫生和陳炳鈞先生。公司設有四個董事會委員會,包括審核委員會、薪酬委員會、提名委員會和業務發展及策略委員會。何建昌先生和Debra Yu醫生分別擔任數個委員會的主席,而其他董事成員則擔任委員會成員。
Pharmaron-B (Cayman) Co., Ltd. announced the list of its board of directors and their roles and functions in each board committee on August 28, 2024. The board of directors includes Executive Director Mr. Liu Min, Non-Executive Director Dr. Li Yiping (Chairman), Ms. Gao Xing, Dr. Sungwon Song, Dr. Liu Cheng, as well as Independent Non-Executive Directors Mr. He Jianchang, Dr. Debra Yu, and Mr. Chen Bingjun. The company has four board committees, including the Audit Committee, the Remuneration Committee, the Nomination Committee, and the Business Development and Strategy Committee. Mr. He Jianchang and Dr. Debra Yu serve as the chairpersons of several committees, while other board members serve as committee members.
Pharmaron-B (Cayman) Co., Ltd. announced the list of its board of directors and their roles and functions in each board committee on August 28, 2024. The board of directors includes Executive Director Mr. Liu Min, Non-Executive Director Dr. Li Yiping (Chairman), Ms. Gao Xing, Dr. Sungwon Song, Dr. Liu Cheng, as well as Independent Non-Executive Directors Mr. He Jianchang, Dr. Debra Yu, and Mr. Chen Bingjun. The company has four board committees, including the Audit Committee, the Remuneration Committee, the Nomination Committee, and the Business Development and Strategy Committee. Mr. He Jianchang and Dr. Debra Yu serve as the chairpersons of several committees, while other board members serve as committee members.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more